These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18416316)

  • 1. [Tumor size and survival in lung cancer, stage IA].
    Lyons G; Quadrelli S; Chimondegy D; Iotti A; Silva C
    Medicina (B Aires); 2008; 68(1):23-30. PubMed ID: 18416316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
    Christian C; Erica S; Morandi U
    Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters.
    Birim O; Kappetein AP; Takkenberg JJ; van Klaveren RJ; Bogers AJ
    Ann Thorac Surg; 2005 Apr; 79(4):1137-41. PubMed ID: 15797040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
    Marchetti A; Bertacca G; Buttitta F; Chella A; Quattrocolo G; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
    Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
    Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size.
    Lee PC; Korst RJ; Port JL; Kerem Y; Kansler AL; Altorki NK
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1382-9. PubMed ID: 17140961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):87-93. PubMed ID: 15632829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
    Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
    Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically predictive factors of pathologic upstaging in patients with peripherally located clinical stage IA non-small cell lung cancer.
    Yamazaki K; Yoshino I; Yohena T; Kameyama T; Tagawa T; Kawano D; Oba T; Koso H; Maehara Y
    Lung Cancer; 2007 Mar; 55(3):365-9. PubMed ID: 17267071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
    Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma.
    Poncelet AJ; Cornet J; Coulon C; Collard P; Noirhomme P; Weynand B;
    Eur J Cardiothorac Surg; 2008 May; 33(5):799-804. PubMed ID: 18374590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor volume is a better prognostic factor than greatest tumor diameter in stage Ia non-small cell lung cancer.
    Tsai CH; Lin CM; Hsieh CC; Hsu WH; Wang HW; Wang LS
    Thorac Cardiovasc Surg; 2006 Dec; 54(8):537-43. PubMed ID: 17151969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial invasion predicts early mortality in stage I non-small cell lung cancer.
    Pechet TT; Carr SR; Collins JE; Cohn HE; Farber JL
    Ann Thorac Surg; 2004 Nov; 78(5):1748-53. PubMed ID: 15511466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
    Chang MY; Mentzer SJ; Colson YL; Linden PA; Jaklitsch MT; Lipsitz SR; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):850-6. PubMed ID: 17903494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer.
    Hsu PK; Huang HC; Hsieh CC; Hsu HS; Wu YC; Huang MH; Hsu WH
    Ann Thorac Surg; 2007 Dec; 84(6):1825-9. PubMed ID: 18036892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
    Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.